Gossamer Bio Competitors and Similar CompaniesClear all

Gossamer Bio's competitors and similar companies include ImmPACT-Bio, Zymeworks and Coherus Oncology.

	Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.	ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.	Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.	Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.
Founding Date	Founding Date 2015	Founding Date 2017	Founding Date 2003	Founding Date 2010
Type	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy
Locations	Locations San Diego, US HQ Dublin 2, IE	Locations Camarillo, US HQ Rishon Le Tsiyon, IL	Locations Vancouver, CA HQ Seattle, US	Locations Redwood City, US HQ Camarillo, US
Employees	Employees 11820% increase	Employees 845% decrease	Employees 45519% increase	Employees 14736% decrease
Valuation ($)	Valuation ($) 208 m	Valuation ($) N/A	Valuation ($) 973.3 m	Valuation ($) 85.6 m
Financial
Revenue (est.)	Revenue (est.) $48.5m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $106m (FY, 2025)	Revenue (est.) $42.2m (FY, 2025)
Net income	Net income ($170.4m) (FY, 2025)	Net income N/A	Net income ($81.1m) (FY, 2025)	Net income $168m (FY, 2025)
Funding
Total funding raised	Total funding raised $ 480m	Total funding raised $ 18m	Total funding raised $ 125.9m	Total funding raised $ 174.5m